- Home
- ARI vs ATAI Comparison
ARI vs ATAI Comparison
Compare ARI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARI | ATAI |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARI | ATAI |
|---|---|---|
| Price | $9.93 | $4.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.83 | ★ $14.33 |
| AVG Volume (30 Days) | 1.0M | ★ 3.2M |
| Earning Date | 02-09-2026 | 11-12-2025 |
| Dividend Yield | ★ 10.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $269,296,000.00 | $3,018,000.00 |
| Revenue This Year | $25.91 | $943.18 |
| Revenue Next Year | $14.63 | N/A |
| P/E Ratio | $11.25 | ★ N/A |
| Revenue Growth | 67.16 | ★ 811.78 |
| 52 Week Low | $7.70 | $1.15 |
| 52 Week High | $11.11 | $6.75 |
Technical Indicators
Market Signals| Indicator | ARI | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 45.74 |
| Support Level | $9.88 | $3.88 |
| Resistance Level | $10.18 | $4.72 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 20.29 | 26.15 |
Price Performance
Historical ComparisonAbout ARI Apollo Commercial Real Estate Finance Inc
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.